WHITEPAPER

Navigating the drug development roadmap: A strategic guide for small molecules and biologics

Get your free downloadable Gantt charts

Bringing a new therapeutic to market is high-risk and high-stakes. While drug development is scientifically complex, it’s often strong planning, not just strong science, that sets successful programmes apart. By proactively aligning timelines, breaking down silos, and recognising key dependencies between Chemistry, Manufacturing and Controls (CMC), safety and efficacy, biotech teams can reduce risk, avoid costly delays, and keep their development on track.

This whitepaper outlines how to avoid common pitfalls by taking a smarter, more integrated approach to development planning. It includes free, downloadable Gantt charts tailored to small molecule and biologic programmes.

These practical tools are designed to help you:

Visualise the entire development path
Identify interdependencies across workstreams
Align cross-functional decisions early
Accelerate regulatory readiness

Whether you're building your roadmap from scratch or pressure-testing your current plan, this guide will help you shorten timelines, reduce risk, and prepare you for each stage with confidence.

You’ll learn

Why poor integration - not poor science - often delays development
How to use Gantt charts as live planning tools, not static timelines
Where Chemistry, Manufacturing and Controls (CMC), toxicology, and clinical development intersect and how early alignment across these functions can de-risk decision-making and support faster, smoother progress
How to avoid common pitfalls like late-stage formulation changes or weak stability data
How early planning improves IND/IMPD submissions and reduces duplication

Who it’s for

Biotech leaders, programme managers, and scientific teams seeking a clear, structured view of their development journey.

Download the whitepaper and gain instant access to Gantt charts built by industry experts - and see how small shifts in planning can deliver big results